These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer. Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Mukojima T; Kawashima R; Fujita T; Tsuji K J Natl Cancer Inst; 1981 Jul; 67(1):47-50. PubMed ID: 6788993 [TBL] [Abstract][Full Text] [Related]
4. Serum Gm system in liver cirrhosis and hepatoma. Theodoropoulos G; Archimandritis A; Drivas G; Kaliakmanis N; Melissinos K Hum Genet; 1980; 56(2):217-9. PubMed ID: 6256282 [TBL] [Abstract][Full Text] [Related]
5. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies. Nakao Y; Matsumoto H; Tsuji K; Miyazaki T; Masaoka T; Nakayama S; Kinoshita K; Shingami T; Matsui T; Fujita T Clin Exp Immunol; 1984 Jun; 56(3):628-36. PubMed ID: 6430611 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin allotypes and immunoreactivity in chronic liver disease. Schmidt W; Königstedt B; Zipprich B; Scheibe E; Nilius R Hepatogastroenterology; 1987 Oct; 34(5):206-11. PubMed ID: 3315922 [TBL] [Abstract][Full Text] [Related]
7. Association between Crohn's disease and immunoglobulin heavy chain (Gm) allotypes. Kagnoff MF; Brown RJ; Schanfield MS Gastroenterology; 1983 Nov; 85(5):1044-7. PubMed ID: 6578156 [TBL] [Abstract][Full Text] [Related]
8. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status. Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531 [TBL] [Abstract][Full Text] [Related]
9. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Bei R; Budillon A; Reale MG; Capuano G; Pomponi D; Budillon G; Frati L; Muraro R Cancer Res; 1999 Nov; 59(21):5471-4. PubMed ID: 10554020 [TBL] [Abstract][Full Text] [Related]
10. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220 [TBL] [Abstract][Full Text] [Related]
11. CD 34 expression in chronic and neoplastic liver diseases. Di Carlo I; Fraggetta F; Lombardo R; Azzarello G; Vasquez E; Puleo S Panminerva Med; 2002 Dec; 44(4):365-7. PubMed ID: 12434120 [TBL] [Abstract][Full Text] [Related]
12. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047 [TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma]. Libman E; Stojsić S; Marton B; Lemberger J Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636 [No Abstract] [Full Text] [Related]
14. Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case. Joske RA; Laurence BH; Matz LR Gastroenterology; 1972 Mar; 62(3):441-4. PubMed ID: 4334824 [No Abstract] [Full Text] [Related]
15. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma. Uehara M; Sato N Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492 [TBL] [Abstract][Full Text] [Related]
16. Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases. Jagirdar J; Thung SN; Shah KD; Nudelman E; Singhal A; Paronetto F Arch Pathol Lab Med; 1992 Jun; 116(6):643-8. PubMed ID: 1352099 [TBL] [Abstract][Full Text] [Related]
17. [Assay of the carcinoembryonic antigen (CEA) in acute and chronic liver diseases and hepatocellular carcinoma]. Piantino P; Gallo V; Pecchio F; Garlanda PF; Bonardi O Minerva Med; 1981 Apr; 72(17):1059-64. PubMed ID: 6262678 [TBL] [Abstract][Full Text] [Related]
18. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients. Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486 [TBL] [Abstract][Full Text] [Related]
19. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394 [TBL] [Abstract][Full Text] [Related]